Atrial fibrillation associated with systemic lupus erythematosus and use of methylprednisolone

American Journal of Therapeutics

Volumn 8, Issue 4, 2001, Pages 303-305

  Khan, Ijaz A ^a  

^a CREIGHTON UNIVERSITY CARDIAC CENTER   (United States)

Author keywords

Arrhythmias; Atrial fibrillation; Methylprednisolone; Myocarditis; Steroids; Systemic lupus erythematosus

Indexed keywords

ANTIINFLAMMATORY AGENT; METHYLPREDNISOLONE;

ADULT; ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANTI-INFLAMMATORY AGENTS; ATRIAL FIBRILLATION; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; LUPUS ERYTHEMATOSUS, SYSTEMIC; METHYLPREDNISOLONE;

EID: 0035405792     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045391-200107000-00013     Document Type: Article

References (5)

1. Moder KG, Miller TD, Tazelaar HD: Cardiac involvement in systemic lupus erythematosus. Mayo Clin Proc 1999;74:275-284.
2. Ansari A, Larson PH, Bates HD: Vascular manifestations of systemic lupus erythematosus. Angiology 1986;37:423-432.
3. Badui E, Garcia-Rubi D, Robles E, et al: Cardiovascular manifestations in systemic lupus erythematosus. Prospective study of 100 patients. Angiology 1985;36:431-441.
4. McLuckie AE, Savage RW: Atrial fibrillation following methylprednisolone therapy in an adult. Chest 1993;104:622-623.
5. Ueda N, Yoshikawa Y, Chihara M, et al: Atrial fibrillation following methylprednisolone pulse therapy. Pediatr Nephrol 1988;2:29-31.